Corporate Governance at Sartorius Stedim Biotech S.A.

Corporate governance aligned with the interests of stakeholders, lawful and responsible conduct, and constructive cooperation between the managerial bodies and within the company in a spirit of mutual trust constitute the essential cornerstones of Sartorius’ corporate culture.

Board of Directors and Committees

According to the definition of the Article L 225 - 18 - 1 and L 22 - 10 - 03 of the French Commercial Code, the Board of Directors of Sartorius Stedim Biotech S.A. is composed of 43% of women as of December 31, 2023. If the employee representative is taken into account, the Board of Directors would be composed of 50% of women.

icon-people

Board of Directors 

Learn More 

The Audit Committee assists the Board of Directors in areas relating to accounting policy, reporting, internal and external control, financial communication and management of the risks to which the company is exposed.

icon-people

Audit Committee

Learn More 

The remuneration and Nomination Committee’s purpose is to assist the company’s Board of Directors in setting the remuneration policy for corporate officers and, in particular, relating to incentive mechanisms (allocation of stock options and bonus shares) that the company may implement.

icon-people

Remuneration and Nomination Committee

Learn More 

Remuneration 

Remuneration of the Executive Board Members 

The remuneration report describes the main features of the remuneration system of the Members of the Board and of the Executive Corporate Officers and provides individualised information on the remuneration due or awarded. 

Remuneration of the Chief Executive Officer 

The remuneration policy 2024 describes the remuneration policy for the Chief Executive Officer for the 2024 financial year, which was decided by the Board of Directors in its meeting held on February 7, 2024, upon proposal of the Remuneration and Nomination Committee, and which will be proposed to the approval of the shareholders’ meeting to be held on March 26, 2024 (ex ante vote).

The remuneration policy 2023 describes the remuneration policy for the Chief Executive Officer from March 28, 2023 to December 31, 2023, which was decided by theBoard of Directors in its meeting heldon March 27, 2023, upon proposal of the Remuneration and Nomination Committee, and which will be proposed to the approval of the next annual shareholders’ meeting.

Corporate Governance Documents 

Pursuant to Article L. 225 - 37 of the French Commercial Code, the Board of Directors uses this report, which covers each fiscal year ended December 31 of each year, to present the conditions of the preparation and organization of the work of the Board of Directors and the internal controlling and control procedures implemented by the company within the Group. 

Please click below to download the documents 

Compliance 
icon-e-mail
Investors Contact